SCHEMBL27259682

SCHEMBL27259682

O=C(O)COc1ccc(Oc2cnc3ccc(Cl)cc3n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
CYP1A2 P05177 3/20 0.60
MAPT P10636 3/20 0.60
CYP3A4 P08684 2/20 0.60
LMNA P02545 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
HPGD P15428 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
TP53 P04637 1/20 0.60
ALOX15 P16050 1/20 0.60
NFKB1 P19838 1/20 0.60
HIF1A Q16665 1/20 0.60
GMNN O75496 1/20 0.60
APEX1 P27695 1/20 0.60
PMP22 Q01453 1/20 0.60
HTT P42858 7/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CYP2C19 P33261 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18579883 0.95 ALDH1A1 (0.55) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL8881655 0.88 ALDH1A1 (0.58) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL27259856 0.85 MEN1 (0.50) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL9410481 0.85 ALDH1A1 (0.55) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL27259726 0.85 HTT (0.53) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL27259698 0.85 MEN1 (0.50) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL27259261 0.85 PTPN7 (0.46) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL18580142 0.84 CYP1A2 (0.54) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL27259274 0.84 PTPN7 (0.44) ALDH1A1CYP1A2MAPTCYP3A4LMNA
SCHEMBL8299472 0.83 ALDH1A1 (0.53) ALDH1A1CYP1A2MAPTCYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024132001-A1 MULTITARGET NUCLEAR RECEPTOR LIGANDS BASED ON 2-(4-(QUINOLIN-2-YLOXY)PHENOXY)PROPANOIC ACID AND 2-(4-(QUINOXALIN-2-YLOXY)PHENOXY)PROPANOIC ACID FOR THE TREATMENT OF METABOLIC AND LIVER DISEASES CHARLES UNIVERSITY, FACULTY OF PHARMACY IN HRADEC KRALOVE (CZ) 2024-06-27 WO disclosed